Nanovibronix, Inc. (NASDAQ:FEED) Short Interest Update

Nanovibronix, Inc. (NASDAQ:FEED) was the target of a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 74,962 shares, a drop of 53.6% from the July 15th total of 161,665 shares. Based on an average daily volume of 202,909 shares, the days-to-cover ratio is presently 0.4 days. Currently, 1.4% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on FEED. Wall Street Zen raised Nanovibronix from a “strong sell” rating to a “sell” rating in a research note on Sunday, July 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a research note on Tuesday, July 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Insider Buying and Selling

In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $0.69, for a total transaction of $144,900.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 12.20% of the company’s stock.

Nanovibronix Stock Up 11.9%

Nanovibronix stock traded up $0.05 during trading on Monday, hitting $0.49. The stock had a trading volume of 375,598 shares, compared to its average volume of 5,565,964. Nanovibronix has a 1 year low of $0.29 and a 1 year high of $17.40. The stock’s 50 day moving average is $0.52 and its two-hundred day moving average is $1.35. The stock has a market cap of $2.98 million, a price-to-earnings ratio of -0.06 and a beta of 1.39.

Nanovibronix (NASDAQ:FEED) last announced its quarterly earnings data on Monday, May 18th. The company reported ($6.88) earnings per share for the quarter. The firm had revenue of $0.65 million for the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.